In this light, Nrf2 emerges as both a buffer against oxidative stress and a guardian of proteostasis, positioning it at the crossroads of stress responses, RNA granule biology, and neurodegeneration, and positioning it as a viable therapeutic axis in ALS. The gene discussed is NFE2L2; the disease is amyotrophic lateral sclerosis.